0001104659-23-120374.txt : 20231121
0001104659-23-120374.hdr.sgml : 20231121
20231121162235
ACCESSION NUMBER: 0001104659-23-120374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231117
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kemble George
CENTRAL INDEX KEY: 0001858176
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41742
FILM NUMBER: 231428438
MAIL ADDRESS:
STREET 1: SAGIMET BIOSCIENCES INC.
STREET 2: 155 BOVET RD., STE. 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sagimet Biosciences Inc.
CENTRAL INDEX KEY: 0001400118
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205991472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 561-8600
MAIL ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
FORMER COMPANY:
FORMER CONFORMED NAME: 3-V Biosciences, Inc.
DATE OF NAME CHANGE: 20070521
4
1
tm2331048-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-17
0
0001400118
Sagimet Biosciences Inc.
SGMT
0001858176
Kemble George
SAGIMET BIOSCIENCES INC.
155 BOVET RD., SUITE 303
SAN MATEO
CA
94402
1
1
0
0
Executive Chairman
0
Series A Common Stock
2023-11-17
4
A
0
150750
0.00
A
156380
D
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Elizabeth Rozek, Attorney-in-Fact
2023-11-21